about
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidat...
Read More
29.87
-0.27
(-0.90%)
14,861
XNAS Volume
XNAS 14 May, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Surrozen Inc is on 19 May 2026 for the purpose of H.C. Wainwright 4(th) Annual BioConnect Investor Conference
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Surrozen Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..